AR039460A1 - Factores camp quimericos - Google Patents
Factores camp quimericosInfo
- Publication number
- AR039460A1 AR039460A1 ARP030101452A ARP030101452A AR039460A1 AR 039460 A1 AR039460 A1 AR 039460A1 AR P030101452 A ARP030101452 A AR P030101452A AR P030101452 A ARP030101452 A AR P030101452A AR 039460 A1 AR039460 A1 AR 039460A1
- Authority
- AR
- Argentina
- Prior art keywords
- camp
- camp factor
- chemical
- uberis
- factor
- Prior art date
Links
- 241000194054 Streptococcus uberis Species 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 241000194017 Streptococcus Species 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 238000010276 construction Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 229940115922 streptococcus uberis Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pregnancy & Childbirth (AREA)
- Communicable Diseases (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Gen del factor CAMP de Streptococcus uberis (S. uberis), así como la producción recombinante del factor CAMP a partir del mismo. También se describen construcciones quiméricas del factor CAMP, inclusive epitopes del factor CAMP de más de una especie bacteriana. Los factores y las quimeras CAMP que incluyen los mismos se pueden usar composiciones inmunogénicas para la prevención y el tratamiento de infecciones bacterianas. también se describe vector, célula huésped, anticuerpos dirigidos contra el polipéptido inmunogénico y un conjunto de elementos de inmunodiagnóstico para detectar la infección por Streptococcus.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/134,021 US6936259B2 (en) | 1995-06-08 | 2002-04-26 | CAMP factor of Streptococcus uberis |
Publications (1)
Publication Number | Publication Date |
---|---|
AR039460A1 true AR039460A1 (es) | 2005-02-23 |
Family
ID=29268791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030101452A AR039460A1 (es) | 2002-04-26 | 2003-04-28 | Factores camp quimericos |
Country Status (10)
Country | Link |
---|---|
US (2) | US6936259B2 (es) |
EP (1) | EP1499726A1 (es) |
JP (1) | JP2005523704A (es) |
AR (1) | AR039460A1 (es) |
AU (1) | AU2003229416B2 (es) |
BR (1) | BRPI0309570B1 (es) |
CA (1) | CA2483564A1 (es) |
MX (1) | MXPA04010646A (es) |
NZ (2) | NZ536232A (es) |
WO (1) | WO2003091437A1 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6833134B2 (en) | 2000-06-12 | 2004-12-21 | University Of Saskacthewan | Immunization of dairy cattle with GapC protein against Streptococcus infection |
US6866855B2 (en) | 2000-06-12 | 2005-03-15 | University Of Saskatchewan | Immunization of dairy cattle with GapC protein against Streptococcus infection |
MXPA03003690A (es) * | 2000-10-27 | 2004-05-05 | Chiron Spa | Acidos nucleicos y proteinas de los grupos a y b de estreptococos. |
AU2003260102A1 (en) * | 2002-08-26 | 2004-03-11 | Chiron Corporation | Conserved and specific streptococcal genomes |
EP1648500B1 (en) | 2003-07-31 | 2014-07-09 | Novartis Vaccines and Diagnostics, Inc. | Immunogenic compositions for streptococcus pyogenes |
US8945589B2 (en) * | 2003-09-15 | 2015-02-03 | Novartis Vaccines And Diagnostics, Srl | Immunogenic compositions for Streptococcus agalactiae |
EP1695086B1 (en) * | 2003-12-09 | 2009-02-18 | BioMerieux, Inc. | Methods for detecting bacterial pathogens |
EP2612679A1 (en) * | 2004-07-29 | 2013-07-10 | Novartis Vaccines and Diagnostics, Inc. | Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae |
JP2008544949A (ja) * | 2004-10-08 | 2008-12-11 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | 化膿性レンサ球菌のための免疫激性組成物および治療用組成物 |
EP1904856A1 (en) * | 2005-07-19 | 2008-04-02 | Badrilla Limited | Agents for and method of quantifying multiple related components in a biological system |
EP2004674B1 (en) | 2006-03-23 | 2013-02-20 | Agriculture Victoria Services Pty Ltd | Antimicrobial protein |
US20110206692A1 (en) * | 2006-06-09 | 2011-08-25 | Novartis Ag | Conformers of bacterial adhesins |
WO2008108830A2 (en) * | 2006-10-30 | 2008-09-12 | Novartis Ag | Immunogenic and therapeutic compositions for streptococcus pyogenes |
WO2008153926A2 (en) | 2007-06-05 | 2008-12-18 | Yale University | Inhibitors of receptor tyrosine kinases and methods of use thereof |
KR101621837B1 (ko) | 2007-09-12 | 2016-05-17 | 노파르티스 아게 | Gas57 돌연변이 항원 및 gas57 항체 |
CN104292312A (zh) | 2007-12-21 | 2015-01-21 | 诺华股份有限公司 | 链球菌溶血素o的突变形式 |
WO2009111838A1 (en) * | 2008-03-13 | 2009-09-17 | Agriculture Victoria Services Pty Limited | Method of treatment using antimicrobial composition |
EP2668210B1 (en) | 2011-01-26 | 2020-06-17 | Celldex Therapeutics, Inc. | Anti-kit antibodies and uses thereof |
AU2013295848B2 (en) | 2012-07-25 | 2018-05-24 | Celldex Therapeutics, Inc. | Anti-KIT antibodies and uses thereof |
CN106659782B (zh) | 2014-05-23 | 2021-11-09 | 塞尔德克斯医疗公司 | 一种用于嗜酸性粒细胞或肥大细胞相关病症治疗的抗体 |
KR101712705B1 (ko) * | 2014-08-19 | 2017-03-07 | 경북대학교 산학협력단 | 스트렙토코커스 애갈락티에 검출용 조성물 및 방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4879213A (en) | 1986-12-05 | 1989-11-07 | Scripps Clinic And Research Foundation | Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse |
EP0626452B1 (en) | 1993-05-17 | 1999-08-11 | Akzo Nobel N.V. | Vaccine against Streptococcus suis infection |
WO1996041879A1 (en) | 1995-06-08 | 1996-12-27 | University Of Saskatchewan | Camp factor of streptococcus uberis |
-
2002
- 2002-04-26 US US10/134,021 patent/US6936259B2/en not_active Expired - Fee Related
-
2003
- 2003-04-24 MX MXPA04010646A patent/MXPA04010646A/es active IP Right Grant
- 2003-04-24 JP JP2003587965A patent/JP2005523704A/ja active Pending
- 2003-04-24 BR BRPI0309570A patent/BRPI0309570B1/pt not_active IP Right Cessation
- 2003-04-24 EP EP03722116A patent/EP1499726A1/en not_active Withdrawn
- 2003-04-24 CA CA002483564A patent/CA2483564A1/en not_active Abandoned
- 2003-04-24 NZ NZ536232A patent/NZ536232A/xx not_active IP Right Cessation
- 2003-04-24 WO PCT/CA2003/000587 patent/WO2003091437A1/en active Application Filing
- 2003-04-24 AU AU2003229416A patent/AU2003229416B2/en not_active Ceased
- 2003-04-24 NZ NZ549506A patent/NZ549506A/en not_active IP Right Cessation
- 2003-04-28 AR ARP030101452A patent/AR039460A1/es unknown
-
2004
- 2004-06-08 US US10/864,012 patent/US7700117B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
BR0309570A (pt) | 2005-02-22 |
CA2483564A1 (en) | 2003-11-06 |
AU2003229416B2 (en) | 2008-05-01 |
MXPA04010646A (es) | 2005-02-17 |
EP1499726A1 (en) | 2005-01-26 |
US7700117B2 (en) | 2010-04-20 |
BRPI0309570B1 (pt) | 2016-12-27 |
US20040219639A1 (en) | 2004-11-04 |
AU2003229416A1 (en) | 2003-11-10 |
JP2005523704A (ja) | 2005-08-11 |
NZ549506A (en) | 2008-08-29 |
NZ536232A (en) | 2006-12-22 |
WO2003091437A1 (en) | 2003-11-06 |
US20030072765A1 (en) | 2003-04-17 |
US6936259B2 (en) | 2005-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR039460A1 (es) | Factores camp quimericos | |
EP4272765A3 (en) | Adeno-associated virus (aav) clade f vector and uses therefor | |
AR027114A1 (es) | Proteinas insecticidas de bacillus thuringiensis | |
PE20091218A1 (es) | Anticuerpo anti-glipicano 3 con cinetica en plasma mejorada | |
AR032231A1 (es) | Nuevas proteinas insecticidas de bacillus thuringiensis | |
PE20060277A1 (es) | Adenovirus quimericos en el tratamiento del cancer | |
PE20110310A1 (es) | Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas | |
ATE541857T1 (de) | Optimierte fc-varianten und herstellungsverfahren dafür | |
NO20054405L (no) | Kjemokinreseptor-binende heterosykel | |
EA201100070A1 (ru) | Туберкулезный белок rv2386c, композиции и их применения | |
ATE519842T1 (de) | Trichoderma reesei-glucoamylase und homologe davon | |
IL172506A0 (en) | New biological entities and the use thereof | |
EA201170878A1 (ru) | Полипептиды с ксиланазной активностью | |
AU2003244855A1 (en) | Method to enhance an immune response of nucleic acid vaccination | |
AR068428A1 (es) | Secuencias peptidicas y composiciones que las comprenden que proveen proteccion contra enfermedades transmitidas por artropodos | |
ES2627117T3 (es) | Método basado en MGMT para obtener un rendimiento elevado de expresión de proteínas recombinantes | |
MX2021000328A (es) | Enzimas de variantes de galactosa oxidasa modificadas geneticamente. | |
ES2622087T3 (es) | Vacuna recombinante contra paramyxovirus aviar y procedimiento de fabricación y utilización de la misma | |
EA201100071A1 (ru) | Новые композиции и способы | |
AR100606A1 (es) | Variantes de lipasas y polinucleótidos que las codifican | |
MX2021000322A (es) | Enzimas de variante fosfopentomutasa modificada geneticamente. | |
DK1675956T3 (da) | Minimal DNA-sekvens, der virksom som chromatinisolator, og dennes anvendelse til proteinekspression | |
ZA202107428B (en) | Porcine circovirus type 3 (pcv3) vaccines, and production and uses thereof | |
BR112022025633A2 (pt) | Adas compreendendo sistemas de secreção bacteriana | |
NO20060568L (no) | Anvendelse av et nytt eimeriagen og tilhorende protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |